Name | Number of supported studies | Average coverage | |
---|---|---|---|
epithelial cell of proximal tubule | 4 studies | 20% ± 3% | |
hepatocyte | 4 studies | 31% ± 12% |
Insufficient scRNA-seq data for expression of ETNK2 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
thymus | 99% | 706.03 | 646 / 653 | 94% | 22.13 | 569 / 605 |
liver | 100% | 6857.87 | 225 / 226 | 91% | 47.52 | 369 / 406 |
breast | 96% | 1456.38 | 442 / 459 | 89% | 25.76 | 995 / 1118 |
ovary | 100% | 1830.74 | 180 / 180 | 83% | 8.76 | 357 / 430 |
kidney | 100% | 5380.01 | 89 / 89 | 78% | 10.81 | 699 / 901 |
skin | 85% | 1076.27 | 1536 / 1809 | 92% | 19.73 | 436 / 472 |
uterus | 100% | 977.02 | 170 / 170 | 65% | 7.34 | 299 / 459 |
brain | 78% | 519.15 | 2058 / 2642 | 78% | 9.08 | 548 / 705 |
adrenal gland | 76% | 397.53 | 196 / 258 | 78% | 15.65 | 179 / 230 |
bladder | 100% | 796.48 | 21 / 21 | 52% | 4.98 | 260 / 504 |
prostate | 100% | 1120.74 | 244 / 245 | 50% | 3.18 | 249 / 502 |
pancreas | 82% | 366.45 | 268 / 328 | 54% | 4.34 | 96 / 178 |
esophagus | 80% | 746.15 | 1154 / 1445 | 48% | 7.10 | 87 / 183 |
lung | 52% | 183.86 | 299 / 578 | 64% | 7.49 | 736 / 1155 |
ureter | 0% | 0 | 0 / 0 | 100% | 7.37 | 1 / 1 |
blood vessel | 100% | 1737.16 | 1330 / 1335 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 96% | 9.65 | 77 / 80 |
adipose | 93% | 962.35 | 1115 / 1204 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 87% | 13.75 | 39 / 45 |
intestine | 71% | 333.93 | 690 / 966 | 12% | 0.86 | 64 / 527 |
spleen | 80% | 530.79 | 192 / 241 | 0% | 0 | 0 / 0 |
stomach | 48% | 243.57 | 171 / 359 | 17% | 1.53 | 49 / 286 |
heart | 48% | 212.40 | 417 / 861 | 0% | 0 | 0 / 0 |
muscle | 4% | 15.33 | 32 / 803 | 0% | 0 | 0 / 0 |
peripheral blood | 1% | 9.58 | 12 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 29 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0016310 | Biological process | phosphorylation |
GO_0035264 | Biological process | multicellular organism growth |
GO_0009791 | Biological process | post-embryonic development |
GO_0001701 | Biological process | in utero embryonic development |
GO_0008150 | Biological process | biological_process |
GO_0006646 | Biological process | phosphatidylethanolamine biosynthetic process |
GO_0001890 | Biological process | placenta development |
GO_0005575 | Cellular component | cellular_component |
GO_0005829 | Cellular component | cytosol |
GO_0005737 | Cellular component | cytoplasm |
GO_0005515 | Molecular function | protein binding |
GO_0005524 | Molecular function | ATP binding |
GO_0004305 | Molecular function | ethanolamine kinase activity |
Gene name | ETNK2 |
Protein name | ethanolamine kinase (EC 2.7.1.82) Ethanolamine kinase 2 (EKI 2) (EC 2.7.1.82) (Ethanolamine kinase-like protein) Alternative protein ETNK2 Ethanolamine kinase 2 |
Synonyms | HMFT1716 EKI2 |
Description | FUNCTION: Highly specific for ethanolamine phosphorylation. Does not have choline kinase activity (By similarity). . |
Accessions | ENST00000429525.1 Q9NVF9 ENST00000367197.5 ENST00000367202.9 [Q9NVF9-1] ENST00000422072.5 Q5SXX7 Q5SXX4 ENST00000367201.7 [Q9NVF9-2] H0Y771 B7ZC34 ENST00000422699.5 ENST00000452983.5 B7ZC35 Q5SXX8 ENST00000444817.1 L8ECH7 |